Natural History of Herpes Zoster in the Placebo Groups of Three Randomized Phase III Clinical Trials
ConclusionThe incidence and burden of HZ is high in immunocompetent adults aged ≥ 50 YOA and even more so in HSCT recipients aged ≥ 18 YOA.Graphical Abstract
Source: Infectious Diseases and Therapy - Category: Infectious Diseases Source Type: research
More News: Clinical Trials | Eyes | Herpes | Infectious Diseases | Pain | Shingles (Herpes Zoster) Vaccine | Stem Cell Therapy | Stem Cells | Study | Transplants | Vaccines | Varicella-Zoster Virus Vaccine